News Eisai: UK gives pharma a poor deal, may invest elsewhere Japanese pharma getting frustrated with NICE
News US regulator approves new use for Pfizer's Sutent FDA granted new kidney cancer indication despite advisers' split decision
News NICE backs funding for Pfizer, Novartis breast cancer drugs Pfizer had been giving drug free to NHS before decision
News Novartis drug shows huge promise in cutting heart attack dea... Novartis look to have a major new treatment for heart disease on its hands, in the shape of canakinumab, a drug which has produced exceptional results in a new phase 3 trial.
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
